Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
The immune response to SARS-CoV-2 in people with HIV
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised …
Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated …
who could be at increased risk of severe illness and death from COVID-19. We evaluated …
[HTML][HTML] Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
J Yin, Y Chen, Y Li, C Wang, X Zhang - International Journal of Infectious …, 2022 - Elsevier
Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …
Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?
M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …
overwhelming our times. Given the enduring immune disfunction featuring people living with …
Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV
H Zhan, H Gao, Y Liu, X Zhang, H Li, X Li… - Journal of medical …, 2023 - Wiley Online Library
This study aimed to investigate the immunogenicity to SARS‐CoV‐2 and evasive
subvariants BA. 4/5 in people living with HIV (PLWH) following a third booster shot of …
subvariants BA. 4/5 in people living with HIV (PLWH) following a third booster shot of …
Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1-infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection
KG Schmidt, EG Harrer, K Tascilar, S Kübel, B El Kenz… - Viruses, 2022 - mdpi.com
Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination
MJ Jongkees, D Geers, KS Hensley… - The Journal of …, 2023 - academic.oup.com
Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine …
LF López-Cortés, A Saborido-Alconchel… - Frontiers in …, 2023 - frontiersin.org
Background Data on SARS-CoV-2 mRNA vaccine immunogenicity in people living with
human immunodeficiency virus (PLWH) and discordant immune response (DIR) are …
human immunodeficiency virus (PLWH) and discordant immune response (DIR) are …
[HTML][HTML] Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort …
JH Ku, LS Sy, L Qian, BK Ackerson, Y Luo, JE Tubert… - Vaccine, 2023 - Elsevier
Background Data on the effectiveness of the 3-dose mRNA-1273 primary series are limited,
particularly in comparison to 2 doses. Given suboptimal COVID-19 vaccine uptake among …
particularly in comparison to 2 doses. Given suboptimal COVID-19 vaccine uptake among …